The Canada-based Danish pharmaceutical company, Novo Nordisk Canada, Inc., had conducted a survey through an online panel of Leger360, the largest research and analytics organization of Canada. This survey was conducted in late February this year with over 1500 participants from Canada. https://www.coherentmarketinsights.com/news/a-portion-of-the-canadian-population-with-chronic-diseases-is-avoiding-treatment-due-to-covid-19-pandemic-327